| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: TYSABRI (natalizumab) | |
| ***************************************************** | |
| #Post#: 4507-------------------------------------------------- | |
| (Abst.) Subq administration of natalizumab can lead to lower dru | |
| g concentrations compared to IV | |
| By: agate Date: August 5, 2024, 6:59 pm | |
| --------------------------------------------------------- | |
| From PubMed (August 5, 2024)--"Subcutaneous administration of | |
| natalizumab can lead to lower drug concentrations compared to | |
| intravenous administration": | |
| https://pubmed.ncbi.nlm.nih.gov/39096666/ | |
| ***************************************************** |